Skip to main content
MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
5.81
-0.05 (-0.85%)
Oct 29, 2024, 4:00 PM EDT - Market closed

MiMedx Group Revenue

MiMedx Group had revenue of $87.21M in the quarter ending June 30, 2024, with 7.32% growth. This brings the company's revenue in the last twelve months to $340.46M, up 15.41% year-over-year. In the year 2023, MiMedx Group had annual revenue of $321.48M with 20.03% growth.

Revenue (ttm)
$340.46M
Revenue Growth
+15.41%
P/S Ratio
2.26
Revenue / Employee
$380,401
Employees
895
Market Cap
852.96M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023321.48M53.64M20.03%
Dec 31, 2022267.84M25.82M10.67%
Dec 31, 2021242.02M-6.22M-2.50%
Dec 31, 2020248.23M-51.02M-17.05%
Dec 31, 2019299.26M-59.86M-16.67%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bioventus 536.89M
HealthStream 287.99M
Cronos Group 101.78M
Zenas BioPharma 50.00M
AbCellera Biologics 33.05M
Silence Therapeutics 22.62M
Revenue Rankings

MDXG News

More News